Leerink Starts Larimar Therapeutics (LRMR) at Outperform
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.91 +2.09%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Join SI Premium – FREE
Leerink analyst Joseph Schwartz initiates coverage on Larimar Therapeutics (NASDAQ: LRMR) with a Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.
Shares of Larimar Therapeutics closed at $3.92 yesterday.
You May Also Be Interested In
- Jefferies Starts Crane NXT (CXT) at Buy, 'Underappreciated Growth and Margin Story'
- Melius Starts Williams Companies (WMB) at Buy
- CapitalOne Starts Energy Transfer (ET) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
